4.4 Article

Risk factors for developing osteonecrosis of jaw in advanced cancer patients underwent zoledronic acid treatment

期刊

FUTURE ONCOLOGY
卷 15, 期 30, 页码 3503-3511

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/fon-2019-0352

关键词

bone metastasis; osteonecrosis of jaw; risk factor; zoledronic acid

类别

资金

  1. National Natural Science Foundation of China [81673102, 81602791, 81803164]
  2. National Key Research and Development Program of China [2016YFC0105409]
  3. Youth Foundation of Shanghai Health and Family Planning Commission [20164Y0066]
  4. Clinical Research Plan of SHDC [16CR1037B]
  5. Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20171904]
  6. Shanghai Jiaotong University Translational Medicine Fund Support [ZH2018QNA54]
  7. special construction of integrated Chinese and Western medicine in general hospital [ZHYY-ZXYJHZ X-2-201704]

向作者/读者索取更多资源

Aim: To investigate the risk factors for developing osteonecrosis of jaw (ONJ) in advanced cancer patients with bone metastases underwent zoledronic acid (ZA) treatment. Materials & methods: Univariate and multivariate logistic regression analyses were performed to investigate factors associated with developing ONJ in advanced cancer patients. Results: A total of 2214 advanced cancer patients were included. Univariate and multivariate logistic regression analyses for risk factors associated with ONJ were older age (>= 66 years, hazards ratio [HR]: 3.21; p = 0.007), anemia (HR: 3.29; p = 0.006) and duration of ZA exposure (between 1 and 2 years, HR: 3.91, p = 0.01; >= 2 years, HR: 8.07, p < 0.001), respectively. Conclusion: Patients with older age, anemia and/or more than 1 year of ZA treatment are at high risk of developing ONJ.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据